384 related articles for article (PubMed ID: 12612295)
1. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma.
Price DB; Hernandez D; Magyar P; Fiterman J; Beeh KM; James IG; Konstantopoulos S; Rojas R; van Noord JA; Pons M; Gilles L; Leff JA;
Thorax; 2003 Mar; 58(3):211-6. PubMed ID: 12612295
[TBL] [Abstract][Full Text] [Related]
2. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma.
Vaquerizo MJ; Casan P; Castillo J; Perpiña M; Sanchis J; Sobradillo V; Valencia A; Verea H; Viejo JL; Villasante C; Gonzalez-Esteban J; Picado C;
Thorax; 2003 Mar; 58(3):204-10. PubMed ID: 12612294
[TBL] [Abstract][Full Text] [Related]
3. Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control.
Barnes N; Laviolette M; Allen D; Flood-Page P; Hargreave F; Corris P; O'Connor B; Tate H; Parker D; Pavord I
Respir Med; 2007 Aug; 101(8):1652-8. PubMed ID: 17481879
[TBL] [Abstract][Full Text] [Related]
4. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening AP; Haahtela T; Holgate ST; Picado C; Menten J; Dass SB; Leff JA; Polos PG
BMJ; 2003 Oct; 327(7420):891. PubMed ID: 14563743
[TBL] [Abstract][Full Text] [Related]
5. Montelukast: a review of its therapeutic potential in persistent asthma.
Jarvis B; Markham A
Drugs; 2000 Apr; 59(4):891-928. PubMed ID: 10804041
[TBL] [Abstract][Full Text] [Related]
6. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
Fish JE; Israel E; Murray JJ; Emmett A; Boone R; Yancey SW; Rickard KA
Chest; 2001 Aug; 120(2):423-30. PubMed ID: 11502639
[TBL] [Abstract][Full Text] [Related]
7. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
[TBL] [Abstract][Full Text] [Related]
8. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.
Malmstrom K; Rodriguez-Gomez G; Guerra J; Villaran C; Piñeiro A; Wei LX; Seidenberg BC; Reiss TF
Ann Intern Med; 1999 Mar; 130(6):487-95. PubMed ID: 10075616
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, randomised, controlled trial assessing controller medications in asthma.
Shah AR; Sharples LD; Solanki RN; Shah KV
Respiration; 2006; 73(4):449-56. PubMed ID: 16407639
[TBL] [Abstract][Full Text] [Related]
10. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.
Reiss TF; Chervinsky P; Dockhorn RJ; Shingo S; Seidenberg B; Edwards TB
Arch Intern Med; 1998 Jun; 158(11):1213-20. PubMed ID: 9625400
[TBL] [Abstract][Full Text] [Related]
11. Treatment with 400 microg of inhaled budesonide vs 200 microg of inhaled budesonide and oral montelukast in children with moderate persistent asthma: randomized controlled trial.
Jat GC; Mathew JL; Singh M
Ann Allergy Asthma Immunol; 2006 Sep; 97(3):397-401. PubMed ID: 17042148
[TBL] [Abstract][Full Text] [Related]
12. Addition of formoterol or montelukast to low-dose budesonide: an efficacy comparison in short- and long-term asthma control.
Ceylan E; Gencer M; Aksoy S
Respiration; 2004; 71(6):594-601. PubMed ID: 15627870
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of once-daily therapy with inhaled corticosteroid, leukotriene antagonist or sustained-release theophylline in patients with mild persistent asthma.
Yurdakul AS; Taci N; Eren A; Sipit T
Respir Med; 2003 Dec; 97(12):1313-9. PubMed ID: 14682413
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
[TBL] [Abstract][Full Text] [Related]
15. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.
Laviolette M; Malmstrom K; Lu S; Chervinsky P; Pujet JC; Peszek I; Zhang J; Reiss TF
Am J Respir Crit Care Med; 1999 Dec; 160(6):1862-8. PubMed ID: 10588598
[TBL] [Abstract][Full Text] [Related]
16. Addition of montelukast versus double dose of inhaled budesonide in moderate persistent asthma.
Yildirim Z; Ozlu T; Bulbul Y; Bayram H
Respirology; 2004 Jun; 9(2):243-8. PubMed ID: 15182276
[TBL] [Abstract][Full Text] [Related]
17. Montelukast vs. inhaled low-dose budesonide as monotherapy in the treatment of mild persistent asthma: a randomized double blind controlled trial.
Kumar V; Ramesh P; Lodha R; Pandey RM; Kabra SK
J Trop Pediatr; 2007 Oct; 53(5):325-30. PubMed ID: 17623754
[TBL] [Abstract][Full Text] [Related]
18. Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
Green RH; Brightling CE; McKenna S; Hargadon B; Neale N; Parker D; Ruse C; Hall IP; Pavord ID
Eur Respir J; 2006 Jun; 27(6):1144-51. PubMed ID: 16455831
[TBL] [Abstract][Full Text] [Related]
19. Spotlight on montelukast in asthma in children 2 to 14 years of age.
Muijsers RB; Noble S
Am J Respir Med; 2002; 1(3):225-8. PubMed ID: 14720060
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma.
Meltzer EO; Lockey RF; Friedman BF; Kalberg C; Goode-Sellers S; Srebro S; Edwards L; Rickard K;
Mayo Clin Proc; 2002 May; 77(5):437-45. PubMed ID: 12004993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
